GENE ONLINE|News &
Opinion
Blog

Gene Therapy
ASGCT 2024 ASGCT Clinical Trials
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
ASGCT 2024 ASGCT Clinical Trials
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Trials & Approvals Gene TherapyRare Disease
Orchard Therapeutics’ Gene Therapy for Rare Neurological Disorder Wins FDA Approval
2024-03-20
R&D MRIGene Therapy
Groundbreaking Real-Time MRI Enhances Nervous System Gene Therapy
2024-01-30
Special biotech
GeneOnline’s Pick: Top 10 Global Biotech News Stories in 2023
2023-12-27
Asia-Pacific acquisition
Ajinomoto to Acquire Forge Biologics for $620 Million to Boost Gene Therapy Capabilities
2023-11-14
Editors' Picks TuberculosisEarly Cancer Detection
GeneOnline’s Weekly News Highlights: June 26-30
2023-07-03
Trials & Approvals Gene Therapymuscular dystrophy
Promising Clinical Data Supports Clinical Initiation of Epic Bio’s FSHD Therapy
2023-06-27
Special Cell and Gene Therapy
Revolutionizing Eye Disease Treatment with iPSC Therapy
2023-03-07
Special Cell and Gene Therapy
Global Head of Research of Kite Pharma Unveiled the Key Elements to Success in Adoptive Cell Therapy
2023-03-07
Trials & Approvals Gene Therapy
CSL’s Hemgenix Wins First Gene Therapy Approval For Hemophilia In Europe
2023-02-21
Trials & Approvals Gene Therapy
Immusoft’s B Cell Gene Therapy Gets FDA Nod to Enter Clinical Trials
2023-02-13
Ranking & Reports Gene Therapy
Patent Landscape Analysis of Gene Therapy
2023-02-08
Regulatory Gene Therapy
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Go Prime Gene Therapy
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
1 2 3 … 9
LATEST
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
Advancements in Alzheimer’s Disease Drug Innovation and Funding Programs in 2024
2024-07-04
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
BIO Asia–Taiwan 2024 Set to Showcase Global Biotech Industry Talent on July 24th
2024-07-03
Novo Nordisk’s CLARION-CKD Trial Shut Down After Unsuccessful Results Causing Impairment Loss
2024-07-03
Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market
2024-07-03
Ginkgo Job Cuts Expected to Affect at Least 35% of Workforce, Eliminating Over 400 Jobs
2024-07-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top